| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |